Long-Term Follow-up of STAT5B Deficiency in Three Argentinian Patients: Clinical and Immunological Features

Journal of Clinical Immunology

Volumn 35, Issue 3, 2015, Pages 264-272

  Bezrodnik, Liliana ^a   Di Giovanni, Daniela ^a   Caldirola, María Soledad ^a   Azcoiti, María Esnaola ^a   Torgerson, Troy ^b,c,d   Gaillard, María Isabel ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Immunology Diagnostic Laboratory within the Center for Immunity and Immunotherapies at Seattle Childrens Research Institute   (United States)

Author keywords

dysregulatory syndrome; growth hormone; lymphocytic interstitial pneumonitis; primary immunodeficiency; regulatory T cells; Stat5B

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2; STAT5B PROTEIN; AUTOANTIBODY; IMMUNOGLOBULIN; STAT5 PROTEIN; STAT5B PROTEIN, HUMAN;

ADULT; ALOPECIA; ARGENTINIAN; ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOSOMAL RECESSIVE DISORDER; BACTERIAL SUPERINFECTION; BLOOD CULTURE; BRONCHUS OBSTRUCTION; CASE REPORT; CELIAC DISEASE; CELL PROLIFERATION; CELLULITIS; CHICKENPOX; CHRONIC DIARRHEA; CHRONIC LUNG DISEASE; EARLY DIAGNOSIS; ECZEMA; FAILURE TO THRIVE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENETIC TRANSCRIPTION; GROWTH DISORDER; HERPES ZOSTER; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHYROIDISM; HYPOXEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; IN VITRO STUDY; INTERSTITIAL PNEUMONIA; KERATITIS; LUNG BIOPSY; LUNG FUNCTION; LYMPHOCYTE SUBPOPULATION; MALABSORPTION; NATURAL KILLER CELL; NONSENSE MUTATION; OTITIS MEDIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMOCYSTIS JIROVECI; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PSORIASIS; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RHODOCOCCUS; SEBORRHEIC DERMATITIS; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B DEFICIENCY; STEATORRHEA; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE SUBPOPULATION; UVEITIS; VISUAL ACUITY; WEIGHT GAIN; YOUNG ADULT; ARGENTINA; B LYMPHOCYTE; BLOOD; DEFICIENCY; GENETICS; IMMUNE DEFICIENCY; IMMUNOLOGY; LYMPHOCYTE COUNT; MUTATION; T LYMPHOCYTE;

ADULT; ARGENTINA; AUTOANTIBODIES; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTE COUNT; MUTATION; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84925511154     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-015-0145-5     Document Type: Article

References (33)

1. Verbsky JW, Chatila TA. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr. 2013;25(6):708–14.
2. Lin JX, Leonard WJ. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene. 2000;19(21):2566–76.
3. Chatila TA. Regulatory T cells: key players in tolerance and autoimmunity. Endocrinol Metab Clin North Am. 2009;38(2):265–72. vii.
4. Antov A et al. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J Immunol. 2003;171(7):3435–41.
5. Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol. 2007;120(4):744–50. quiz 751–2.
6. Bernasconi A et al. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics. 2006;118(5):e1584–92.
7. Cavallo MC, Llugdar J, Lozano NA, Pacoricona DL, Lozano A. Inmunodeficiencia primaria con deficit de crecimiento: rol de STAT5b. CIMEL. 2006;11:96–100.
8. Hwa V et al. Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b gene. Horm Res. 2007;68(5):218–24.
9. Hwa V et al. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab. 2005;90(7):4260–6.
10. Kofoed EM et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med. 2003;349(12):1139–47.
11. Pugliese-Pires PN et al. A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings. Eur J Endocrinol. 2010;163(2):349–55.
12. Scaglia PA et al. A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease. J Clin Endocrinol Metab. 2012;97(5):E830–9.
13. Vidarsdottir S et al. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J Clin Endocrinol Metab. 2006;91(9):3482–5.
14. Kanai T, Jenks J, Nadeau KC. The STAT5b pathway defect and autoimmunity. Front Immunol. 2012;14(3):234.
15. Cohen AC et al. Cutting edge: decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. J Immunol. 2006;177(5):2770–4.
16. Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity. 2012;36(4):515–28.
17. Udy GB et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A. 1997;94(14):7239–44.
18. Ayling RM et al. A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat Genet. 1997;16(1):13–4.
19. Duquesnoy P et al. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J. 1994;13(6):1386–95.
20. Yao Z et al. Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci U S A. 2006;103(4):1000–5.
21. Burchill MA et al. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol. 2003;171(11):5853–64.
22. Yao Z et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood. 2007;109(10):4368–75.
23. Murawski MR et al. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis. Ann N Y Acad Sci. 2006;1079:198–204.
24. Bezrodnik L et al. Follicular bronchiolitis as phenotype associated with Cd25 Deficiency. Clin Exp Immunol. 2014;175:227–34.
25. Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW. CD25 deficiency causes an immune dysregulation, polyendocvronophaty, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol. 2007;119:482.
26. Goudy K, Aydin D, Barzaghi F, Gambineri E, Vignoli M, Ciullini Mannurita S, et al. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immun. 2013;146:248–61.
27. Sharfe N, Dadi HK, Shahar M, Roifman CM. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci. 1997;94(7):3168–71.
28. Imada K et al. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med. 1998;188(11):2067–74.
29. Behbod F et al. Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells. J Immunol. 2003;171(8):3919–27.
30. Jenks JA et al. Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. Clin Immunol. 2013;148(2):227–36.
31. Goetz CA et al. STAT5 activation underlies IL7 receptor-dependent B cell development. J Immunol. 2004;172(8):4770–8.
32. Dorner T et al. Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods. 2011;363(2):187–97.
33. Snow JW et al. Bone marrow transplant completely rescues hematolymphoid defects in STAT5A/5B-deficient mice. Exp Hematol. 2003;31(12):1247–52.